Whitepapers
The Hidden Cost of Deferring HPAPI Strategy
- Back
-
- February 2, 2026
-
Author
Wilmington PharmaTech - Tag: Whitepapers
Abstract
HPAPI strategy is frequently postponed in early development despite its far-reaching implications beyond worker safety. Containment philosophy, facility selection, partner choice, and validation approaches become structurally embedded as programs advance, narrowing flexibility and increasing the cost of change. This paper outlines a decision-timing framework for HPAPI development, demonstrating how early alignment on containment and facility strategy prevents late-stage disruption, regulatory risk, and operational dead-ends.